The Eurasian Patent Organization (EAPO) has granted Patent, protecting the company’s sublingual delivery technology for anticancer drugs used to treat autoimmune and neurodegenerative diseases
AVT03 is a biosimilar of Amgen's Prolia (denosumab 60 mg/mL) and Xgeva (denosumab 70 mg/mL), which are used to treat various bone conditions
The partnership will enable rapid and reliable product delivery
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
Desai is currently serving the company as Group Finance Controller
Winlevi is authorized in EU for the treatment of acne vulgaris
Tofacitinib extended-release tablets are a Janus kinase inhibitor indicated for Rheumatoid Arthritis
The company says the innovation delivers stronger moisture protection for highly sensitive drug molecules
Subscribe To Our Newsletter & Stay Updated